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Symptom monitoring during chemotherapy via web-based patient-reported
outcomes (PROs) was previously demonstrated to lengthen survival in a single-
center study.1 A multicenter randomized clinical trial compared web-based
monitoring vs standard scheduled imaging to detect symptomatic recurrence in
patients with lung cancer following initial treatment. A planned interim analysis (9-
month follow-up) found a significant survival benefit (19-month survival in the PRO
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